Literature DB >> 26952514

Prognostic significance of GRP78/BiP expression in patients with Stage III/IV hypopharyngeal squamous cell carcinoma.

K Kaira, M Toyoda, A Shimizu, H Imai, K Sakakura, O Nikkuni, M Suzuki, M Iijima, T Asao, K Chikamatsu.   

Abstract

The immunoglobulin heavy chain binding protein (BiP)/glucose-regulated protein 78 (GRP78) plays an essential role in the endoplasmic reticulum (ER) stress, and GRP78/BiP is known to be highly expressed in various human neoplasms. The clinicopathological features of GRP78/BiP expression in patients with advanced hypopharyngeal squamous cell carcinoma (HSCC) remain unclear. The aim of this study is to elucidate the prognostic significance of GRP78/BiP for HSCC.A total of 68 patients with advanced HSCC (stage III/IV) were analyzed, and tumor specimens were stained with immunohistochemistry for GRP78/BiP, Ki-67, and microvessel density (MVD), as determined through CD34 and p53 levels. GRP78/BiP was highly expressed in 80.8% (55/68) of all patients. The expression level of GRP78/BiP disclosed no significant relationship with any variables. Multivariate analysis confirmed that low expression of GRP78/BiP was an independent prognostic factor for predicting poor overall survival and progression-free survival in patients with advanced HSCC. The decreasing expression of GRP78/BiP was identified as a significant predictor related to shorter survival duration after surgery for advanced HSCC. Our study suggests that the reduced expression of GRP78/BiP contributes to worse survival for patients with advanced head and neck cancer.

Entities:  

Keywords:  ER stress; GRP78/BiP; head and neck cancer; hypopharynx; immunohistochemistry.; squamous cell carcinoma

Mesh:

Substances:

Year:  2016        PMID: 26952514     DOI: 10.4149/319_151002N513

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  2 in total

1.  High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma.

Authors:  Yosuke Miura; Kyoichi Kaira; Reiko Sakurai; Hisao Imai; Yoshio Tomizawa; Noriaki Sunaga; Koichi Minato; Takeshi Hisada; Tetsunari Oyama; Masanobu Yamada
Journal:  Int J Clin Oncol       Date:  2017-05-26       Impact factor: 3.402

2.  Aberrantly expressed genes and miRNAs in human hypopharyngeal squamous cell carcinoma based on RNA‑sequencing analysis.

Authors:  Hu Li; Fuling Wang; Yonghua Fei; Yanhua Lei; Fengxiang Lu; Ping Guo; Wei Li; Xuehong Xun
Journal:  Oncol Rep       Date:  2018-06-19       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.